| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 8 |
| 1 | CINACALCET | 5 |
| 2 | OCTREOTIDE ACETATE | 4 |
| 3 | ZOLEDRONIC ACID | 4 |
| 4 | CINACALCET HYDROCHLORIDE | 3 |
| 5 | EVEROLIMUS | 3 |
| 6 | EVEROLIMUS TABLETS | 3 |
| 7 | CARBOPLATIN | 2 |
| 8 | PACLITAXEL | 2 |
| 9 | PACLITAXEL (AIBUMIN-BOUND) | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAMIDRONATE DISODIUM | 2 | 0.0006 |
| 1 | PASIREOTIDE | 1 | 0.0004 |
| 2 | EVEROLIMUS TABLETS | 3 | 0.0002 |
| 3 | OCTREOTIDE ACETATE | 4 | 0.0001 |
| 4 | ZOLEDRONIC ACID | 4 | 0.0001 |
| 5 | ROMOSOZUMAB-AQQG | 1 | 0.0001 |
| 6 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 1 | 0.0001 |
| 7 | CINACALCET HYDROCHLORIDE | 3 | 0.0001 |
| 8 | EVEROLIMUS | 3 | 0.0001 |
| 9 | SUNITINIB MALATE | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 1 | RANK Ligand Inhibitor [EPC] | 8 | 0.0000 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 4 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 6 | Aromatase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Kinase Inhibitor [EPC] | 3 | 0.0000 |